Trial Profile
Ciprofloxacin for Prevention of BK Infection in Renal Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2021
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Bacterial infections; Human polyomavirus infections; Polyomavirus infections
- Focus Therapeutic Use
- 25 Oct 2019 Status changed from recruiting to completed.
- 15 Mar 2016 Planned End Date changed from 1 Jan 2016 to 1 Jun 2017 as per ClinicalTrials.gov record.
- 18 Feb 2013 New trial record